Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Assets Average (2021 - 2025)

Historic Assets Average for Bolt Biotherapeutics (BOLT) over the last 5 years, with Q3 2025 value amounting to $70.3 million.

  • Bolt Biotherapeutics' Assets Average fell 3980.9% to $70.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.3 million, marking a year-over-year decrease of 3980.9%. This contributed to the annual value of $129.7 million for FY2024, which is 3306.97% down from last year.
  • According to the latest figures from Q3 2025, Bolt Biotherapeutics' Assets Average is $70.3 million, which was down 3980.9% from $80.7 million recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' Assets Average ranged from a high of $340.3 million in Q3 2021 and a low of $70.3 million during Q3 2025
  • In the last 5 years, Bolt Biotherapeutics' Assets Average had a median value of $185.6 million in 2021 and averaged $197.6 million.
  • As far as peak fluctuations go, Bolt Biotherapeutics' Assets Average soared by 5909.06% in 2022, and later tumbled by 3980.9% in 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Assets Average (Quarter) stood at $320.6 million in 2021, then dropped by 26.19% to $236.7 million in 2022, then decreased by 29.19% to $167.6 million in 2023, then plummeted by 37.65% to $104.5 million in 2024, then crashed by 32.74% to $70.3 million in 2025.
  • Its Assets Average was $70.3 million in Q3 2025, compared to $80.7 million in Q2 2025 and $92.7 million in Q1 2025.